Poultry
xClose

Loading ...
Swine
xClose

Loading ...
Dairy & Ruminant
xClose

Loading ...
Aquaculture
xClose

Loading ...
Feed
xClose

Loading ...
Animal Health
xClose

Loading ...
Animal Health
Friday, April 21, 2017 5:21:38 PM
Print this articleForward this article

 
Stalosan® F delivers powerful punch to PEDv
 
 

Josef Menge, direct sales of commercial products at Vilomix

 

 

PEDv, a viral disease to which suckling pigs and newly weaned piglets are particularly vulnerable, now looks to have a powerful opponent. Researchers at the University of Minnesota have shown that Stalosan F is particularly effective against PEDv.

 

PEDv has caused significant losses for a number of years in the United States, China and Eastern Europe. Although it is now tapering off in the US, the status remains unchanged in China and Eastern Europe. In order to evaluate the possibilities of limiting this disease on an international level, Vitfoss decided earlier this year to have researchers look at whether Stalosan F, already known for being effective against PRRS virus as well as Salmonella- and Lawsonia bacteria, has any effect against PEDv.

 

Results from a series of lab tests at the University of Minnesota show that Stalosan has a significant effect on PEDv.

 

Effectiveness of 99,9 %

 

"The results obtained by the researchers are extremely interesting. So it is significant that Stalosan F appears to have a particularly good effect, as it almost completely eliminated the PED virus in trials. According to the trials it is 99.9% effective," says Ivan Gospodinov, who oversaw trial design in cooperation with the University of Minnesota, USA.

 

Efficacy of Stalosan F against PEDv

 
 

Results from the University of Minnesota, from professor of virology Sagar M. Goyal. August 2015

 

The clear messages from American researchers mean that Vitfoss is now gearing up to market Stalosan F and the product's efficacy to prevent and fight PEDv in those areas of the world where the diseases remains a problem.

 

PEDv results in reduced appetite, diarrhoea and vomiting

 

PEDv is a major problem in many countries, so we now want to drill down on getting the news and the product out to the affected areas and to minimise spread of the disease," says Dr Ivan Gospodinov.

 

Danish veterinarian Pia Conradsen, from Svinevet, applauds the new results.

 

"In addition to the fact that infected herds need to be immunised, step two is then to reduce infection pressure. This is where the results from the Stalosan F tests are immensely interesting: until now we did not have any effective agents against it," says Conradsen, who also stresses that it is important to reduce infection pressure on infected properties, just as it is critical to limit risk of spreading the infection during transport between herds.

 

The unique effectiveness of Stalosan® F:

 

Stalosan F was launched in 1965 and is a disinfectant with documented efficacy. It has been used in more than 50 countries for 50 years.

 

Vitfoss owns the rights to manufacture, market and sell Stalosan F in Denmark. It is the Vilofoss group (which like Vitfoss is part of the DLG group) that operates on the international level.

 

Stalosan F is a Biosecurity product that is very significant when it comes to creating good economic conditions in operations, including the prevention and treatment of PEDv.

 

Stalosan F, which is a disinfectant that binds ammonia and water, is effective against pathogens including Salmonella, PRRS, Lawsonia and PEDv. Generally, we see that Stalosan used in livestock helps reduce mortality, reduce dependence on medicines, increase daily growth and improve feed utilisation.

 

One of the many advantages of Stalosan is that it can be used in pens while the animals are present. It works within seven days on average, and there are no negative effects on the environment or on equipment.

 

The Stalosan specialists at Vitfoss are trained veterinarians.

 

Authors of the report:

 

Dr. Ivan Gospodinov (igo@stalosan.com), Dr. Plamen Nikolov (pvn@stalosan.com),
Ewa Nick (eni@vitfoss.dk), Dr. Seferinov Tihomir (sfs@stalosan.com) and
Dr. Chavdar Zemyarski (caz@stalosan.com).
The Stalosan team consists of scientific staff and trained veterinarians. Denmark 2015

 

 

For more of the article, please click here.

  

Article made possible through the contribution of Josef Menge and Vilomix

Share this article on FacebookShare this article on TwitterPrint this articleForward this article
Previous
My eFeedLink last read